Arcutis Biotherapeutics, Inc.

NasdaqGS:ARQT 주식 보고서

시가총액: US$1.1b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Arcutis Biotherapeutics 소유권

주요 주주는 누구이며 내부자가 매수 또는 매도한 적이 있나요?

최근 내부자 거래

NasdaqGS:ARQT 회사 또는 개인의 최근 내부자 거래
날짜가치이름엔티티역할공유최대 가격
29 May 24SellUS$435,387Patrick BurnettIndividual49,952US$8.72
28 May 24SellUS$15,988Masaru MatsudaIndividual1,775US$9.01
17 May 24SellUS$68,582Larry EdwardsIndividual7,640US$8.98
02 May 24SellUS$40,902Matthew MooreIndividual4,681US$8.74
04 Mar 24BuyUS$199,994Frazier Life Sciences Management, LPCompany21,052US$9.50
04 Mar 24SellUS$38,568Matthew MooreIndividual3,468US$11.12
04 Mar 24BuyUS$199,994Frazier Life Sciences Management, LPCompany21,052US$9.50
02 Jan 24SellUS$4,692Patrick BurnettIndividual1,325US$3.54
01 Dec 23BuyUS$9,334Todd WatanabeIndividual1,463US$6.38
21 Nov 23SellUS$3,661Masaru MatsudaIndividual1,850US$1.98
24 Oct 23BuyUS$200,000Frazier Life Sciences Management, LPCompany80,000US$2.50
21 Aug 23SellUS$11,302Patrick BurnettIndividual1,605US$7.05

내부자 거래량

내부자 구매: ARQT insiders는 지난 3개월 동안 주식만 판매했습니다.

소유권 분석

ARQT 의 소유 구조는 어떻게 되나요?
소유자 유형공유 수소유권 비율
민간 기업2,3880.00186%
개인 내부자2,333,5971.82%
VC/PE 기업8,785,2846.85%
헤지 펀드15,387,29712%
교육기관101,803,44879.3%

주식의 희석: 지난 해 주주 수는 상당히 희석되었으며, 총 발행 주식 수는 88.5% 만큼 증가했습니다.

최대 주주

상위 25 주주가 회사의 88.12%를 소유하고 있습니다.
소유권이름공유현재 값변경 %포트폴리오 %
10.5%
Jennison Associates LLC
12,176,315US$113.2m34.3%0.07%
7.59%
Frazier Life Sciences Management, LP
8,785,284US$81.7m0.24%3.92%
7.59%
State Street Global Advisors, Inc.
8,784,038US$81.7m476%데이터 없음
6.8%
Suvretta Capital Management, LLC
7,877,297US$73.3m-7.03%3.17%
6.49%
Rubric Capital Management LP
7,510,000US$69.8m13%1.45%
5.95%
Polar Capital Holdings Plc
6,885,922US$64.0m9.34%0.25%
5.75%
BlackRock, Inc.
6,658,741US$61.9m12.5%데이터 없음
4.46%
The Vanguard Group, Inc.
5,166,417US$48.0m5.51%데이터 없음
4.01%
Franklin Resources, Inc.
4,642,220US$43.2m-0.29%0.02%
3.66%
Gilder Gagnon Howe & Co. LLC
4,234,951US$39.4m0%0.5%
3.42%
Morgan Stanley, Investment Banking and Brokerage Investments
3,962,841US$36.9m-34.7%데이터 없음
2.57%
Ensign Peak Advisors, Inc.
2,980,347US$27.7m46.8%0.05%
1.91%
StemPoint Capital LP
2,205,899US$20.5m-15%6.39%
1.84%
Cormorant Asset Management, LP
2,125,000US$19.8m0%1.14%
1.75%
Pivotal BioVenture Partners LLC
2,028,008US$18.9m6.18%8.6%
1.74%
Bain Capital Life Sciences Investors, LLC
2,011,687US$18.7m-32.9%2.04%
1.7%
Geode Capital Management, LLC
1,971,433US$18.3m13.1%데이터 없음
1.65%
Citadel Advisors LLC
1,914,270US$17.8m0%0.02%
1.62%
Deutsche Asset & Wealth Management
1,872,605US$17.4m34.3%0.01%
1.54%
Farallon Capital Management, L.L.C.
1,780,000US$16.6m0%0.12%
1.49%
GW&K Investment Management, LLC
1,721,253US$16.0m4.93%0.14%
1.24%
J. Goldman & Co., L.P.
1,435,318US$13.3m756%0.62%
1.12%
Braidwell LP
1,300,000US$12.1m0%0.78%
0.9%
American Century Investment Management Inc
1,040,946US$9.7m14.2%0.01%
0.81%
Voloridge Investment Management, LLC
943,467US$8.8m0%0.03%